Apple Watch (AAPL) Blood Oxygen Feature Reintroduced in US After Legal Battle

Apple Inc. (NASDAQ:AAPL) is placed 4th on our list of the best stocks to buy. On August 14, Apple announced that it is restoring the blood oxygen tracking feature on Apple Watches in the US after settling a long legal battle with Masimo Corp.

The company is bringing back the blood oxygen feature through its new iOS 18.6.1 and watchOS 11.6.1 updates. The feature was taken off in late 2023 because of a patent lawsuit and a US Customs order.

Apple changed how its blood oxygen feature works. Instead of showing the results directly on the Apple Watch, the data is now processed on the paired iPhone, and users can see the results in the Respiratory section of the Health app.

The company mentioned that this update was allowed by a recent US Customs ruling. The update applies to American users of Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 that were sold with the blood oxygen feature turned off. Watches that already have the feature, or those bought outside the United States, will not be affected.

While we acknowledge the potential of AAPL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Dow 20 Stocks List: Ranked By Hedge Fund Bullishness Index and 10 Unstoppable Dividend Stocks to Buy Now.

Disclosure. None.